APO Research
Talk to an analyst

APO RESEARCH · REPORT

Flu Prevention

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Flu Prevention Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025198 pages

Choose your research edition.

Industry ResearchFlu Prevention Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Flu Prevention Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Flu Prevention Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Flu Prevention Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Flu Prevention Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Flu Prevention market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Flu Prevention is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Flu Prevention include AstraZeneca, BCHT, CSL, KM Biologics, Sinovac, GSK, Hualan Bio, Viatris and Jiangsu GDK, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Flu Prevention market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Flu Prevention and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Flu Prevention sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Flu Prevention market size, projected growth trends, production technologies, key applications, and end-use industries.

Flu Prevention Segment by Company

AstraZeneca

BCHT

CSL

KM Biologics

Sinovac

GSK

Hualan Bio

Viatris

Jiangsu GDK

Sanofi

Changchun Institute of Biological

Flu Prevention Segment by Type

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

Flu Prevention Segment by Application

6 Months to 3 Years

> 3 Years

Flu Prevention Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Flu Prevention market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Flu Prevention and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Flu Prevention.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Flu Prevention market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Flu Prevention manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Flu Prevention in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Flu Prevention in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Flu Prevention Industry Trends Table 2. Flu Prevention Industry Drivers Table 3. Flu Prevention Industry Opportunities and Challenges Table 4. Flu Prevention Industry Restraints Table 5. Global Flu Prevention Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Flu Prevention Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Flu Prevention Sales by Manufacturers (M Doses) & (2021-2026) Table 8. Global Flu Prevention Sales Market Share by Manufacturers Table 9. Global Flu Prevention Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Flu Prevention Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Flu Prevention Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Flu Prevention Manufacturers, Product Type & Application Table 13. Global Flu Prevention Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Flu Prevention by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Trivalent Influenza Vaccine Table 17. Major Manufacturers of Quadrivalent Influenza Vaccine Table 18. Global Flu Prevention Sales by Type 2021 VS 2025 VS 2032 (M Doses) Table 19. Global Flu Prevention Sales by Type (2021-2026) & (M Doses) Table 20. Global Flu Prevention Sales by Type (2027-2032) & (M Doses) Table 21. Global Flu Prevention Sales Market Share by Type (2021-2026) Table 22. Global Flu Prevention Sales Market Share by Type (2027-2032) Table 23. Global Flu Prevention Revenue by Type 2021 VS 2025 VS 2032 (M Doses) Table 24. Global Flu Prevention Revenue by Type (2021-2026) & (M Doses) Table 25. Global Flu Prevention Revenue by Type (2027-2032) & (M Doses) Table 26. Global Flu Prevention Revenue Market Share by Type (2021-2026) Table 27. Global Flu Prevention Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of 6 Months to 3 Years Table 29. Major Manufacturers of > 3 Years Table 30. Global Flu Prevention Sales by Application 2021 VS 2025 VS 2032 (M Doses) Table 31. Global Flu Prevention Sales by Application (2021-2026) & (M Doses) Table 32. Global Flu Prevention Sales by Application (2027-2032) & (M Doses) Table 33. Global Flu Prevention Sales Market Share by Application (2021-2026) Table 34. Global Flu Prevention Sales Market Share by Application (2027-2032) Table 35. Global Flu Prevention Revenue by Application 2021 VS 2025 VS 2032 (M Doses) Table 36. Global Flu Prevention Revenue by Application (2021-2026) & (M Doses) Table 37. Global Flu Prevention Revenue by Application (2027-2032) & (M Doses) Table 38. Global Flu Prevention Revenue Market Share by Application (2021-2026) Table 39. Global Flu Prevention Revenue Market Share by Application (2027-2032) Table 40. Global Flu Prevention Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 41. Global Flu Prevention Sales by Region (2021-2026) & (M Doses) Table 42. Global Flu Prevention Sales Market Share by Region (2021-2026) Table 43. Global Flu Prevention Sales Forecasted by Region (2027-2032) & (M Doses) Table 44. Global Flu Prevention Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 46. North America Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 47. North America Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 48. Europe Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 49. Europe Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 50. Europe Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 51. Asia Pacific Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 52. Asia Pacific Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 53. Asia Pacific Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 54. South America, Middle East and Africa Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Doses) Table 55. South America, Middle East and Africa Flu Prevention Sales by Country (2021-2026) & (M Doses) Table 56. South America, Middle East and Africa Flu Prevention Sales by Country (2027-2032) & (M Doses) Table 57. Global Flu Prevention Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Flu Prevention Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Flu Prevention Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Flu Prevention Revenue Market Share by Region (2021-2026) Table 61. Global Flu Prevention Revenue Market Share by Region (2027-2032) Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca Flu Prevention Product Portfolio Table 66. AstraZeneca Recent Development Table 67. BCHT Company Information Table 68. BCHT Business Overview Table 69. BCHT Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. BCHT Flu Prevention Product Portfolio Table 71. BCHT Recent Development Table 72. CSL Company Information Table 73. CSL Business Overview Table 74. CSL Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. CSL Flu Prevention Product Portfolio Table 76. CSL Recent Development Table 77. KM Biologics Company Information Table 78. KM Biologics Business Overview Table 79. KM Biologics Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. KM Biologics Flu Prevention Product Portfolio Table 81. KM Biologics Recent Development Table 82. Sinovac Company Information Table 83. Sinovac Business Overview Table 84. Sinovac Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Sinovac Flu Prevention Product Portfolio Table 86. Sinovac Recent Development Table 87. GSK Company Information Table 88. GSK Business Overview Table 89. GSK Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. GSK Flu Prevention Product Portfolio Table 91. GSK Recent Development Table 92. Hualan Bio Company Information Table 93. Hualan Bio Business Overview Table 94. Hualan Bio Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Hualan Bio Flu Prevention Product Portfolio Table 96. Hualan Bio Recent Development Table 97. Viatris Company Information Table 98. Viatris Business Overview Table 99. Viatris Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Viatris Flu Prevention Product Portfolio Table 101. Viatris Recent Development Table 102. Jiangsu GDK Company Information Table 103. Jiangsu GDK Business Overview Table 104. Jiangsu GDK Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Jiangsu GDK Flu Prevention Product Portfolio Table 106. Jiangsu GDK Recent Development Table 107. Sanofi Company Information Table 108. Sanofi Business Overview Table 109. Sanofi Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Sanofi Flu Prevention Product Portfolio Table 111. Sanofi Recent Development Table 112. Changchun Institute of Biological Company Information Table 113. Changchun Institute of Biological Business Overview Table 114. Changchun Institute of Biological Flu Prevention Sales (M Doses), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Changchun Institute of Biological Flu Prevention Product Portfolio Table 116. Changchun Institute of Biological Recent Development Table 117. Key Raw Materials Table 118. Raw Materials Key Suppliers Table 119. Flu Prevention Distributors List Table 120. Flu Prevention Customers List Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Flu Prevention Product Image Figure 2. Global Flu Prevention Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Flu Prevention Market Size (2021-2032) & (US$ Million) Figure 4. Global Flu Prevention Sales (2021-2032) & (M Doses) Figure 5. Global Flu Prevention Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Flu Prevention Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Trivalent Influenza Vaccine Image Figure 9. Quadrivalent Influenza Vaccine Image Figure 10. Global Flu Prevention Sales by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 11. Global Flu Prevention Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Flu Prevention Sales Market Share by Type (2021-2032) Figure 13. Global Flu Prevention Revenue by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 14. Global Flu Prevention Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Flu Prevention Revenue Market Share by Type (2021-2032) Figure 16. 6 Months to 3 Years Image Figure 17. > 3 Years Image Figure 18. Global Flu Prevention Sales by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 19. Global Flu Prevention Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Flu Prevention Sales Market Share by Application (2021-2032) Figure 21. Global Flu Prevention Revenue by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Flu Prevention Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Flu Prevention Revenue Market Share by Application (2021-2032) Figure 24. North America Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 25. North America Flu Prevention Sales Market Share by Country (2021-2032) Figure 26. U.S. Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 27. Canada Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 28. Mexico Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 29. Europe Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 30. Europe Flu Prevention Sales Market Share by Country (2021-2032) Figure 31. Germany Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 32. France Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 33. U.K. Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 34. Italy Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 35. Netherlands Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 36. Asia Pacific Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 37. Asia Pacific Flu Prevention Sales Market Share by Country (2021-2032) Figure 38. China Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 39. Japan Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 40. South Korea Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 41. Southeast Asia Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 42. India Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 43. Australia Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 44. South America, Middle East and Africa Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 45. South America, Middle East and Africa Flu Prevention Sales Market Share by Country (2021-2032) Figure 46. Brazil Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 47. South Africa Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 48. Saudi Arabia Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 49. Turkey Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 50. Argentina Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 51. UAE Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 52. Egypt Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 53. Chile Flu Prevention Sales and Growth Rate (2021-2032) & (M Doses) Figure 54. Global Flu Prevention Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Flu Prevention Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Flu Prevention Revenue (2021-2032) & (US$ Million) Figure 57. North America Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Flu Prevention Revenue (2021-2032) & (US$ Million) Figure 59. Europe Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Flu Prevention Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Flu Prevention Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Flu Prevention Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Flu Prevention Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent Influenza Vaccine
  • Quadrivalent Influenza Vaccine
Applications
  • 6 Months to 3 Years
  • > 3 Years
Companies covered
  • AstraZeneca
  • BCHT
  • CSL
  • KM Biologics
  • Sinovac
  • GSK
  • Hualan Bio
  • Viatris
  • Jiangsu GDK
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Flu Prevention Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Flu Prevention Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Flu Prevention Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Flu Prevention Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Flu Prevention Market Dynamics
  1. 2.1 Flu Prevention Industry Trends
  2. 2.2 Flu Prevention Industry Drivers
  3. 2.3 Flu Prevention Industry Opportunities and Challenges
  4. 2.4 Flu Prevention Industry Restraints
3 Flu Prevention Market by Manufacturers
  1. 3.1 Global Flu Prevention Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Flu Prevention Sales by Manufacturers (2021-2026)
  3. 3.3 Global Flu Prevention Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Flu Prevention Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Flu Prevention Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Flu Prevention Manufacturers, Product Type & Application
  7. 3.7 Global Flu Prevention Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Flu Prevention Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Flu Prevention Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Flu Prevention Tier 1, Tier 2, and Tier 3
4 Flu Prevention Market by Type
  1. 4.1 Flu Prevention Type Introduction
  2. 4.1.1 Trivalent Influenza Vaccine
  3. 4.1.2 Quadrivalent Influenza Vaccine
  4. 4.2 Global Flu Prevention Sales by Type
  5. 4.2.1 Global Flu Prevention Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Flu Prevention Sales by Type (2021-2032)
  7. 4.2.3 Global Flu Prevention Sales Market Share by Type (2021-2032)
  8. 4.3 Global Flu Prevention Revenue by Type
  9. 4.3.1 Global Flu Prevention Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Flu Prevention Revenue by Type (2021-2032)
  11. 4.3.3 Global Flu Prevention Revenue Market Share by Type (2021-2032)
5 Flu Prevention Market by Application
  1. 5.1 Flu Prevention Application Introduction
  2. 5.1.1 6 Months to 3 Years
  3. 5.1.2 > 3 Years
  4. 5.2 Global Flu Prevention Sales by Application
  5. 5.2.1 Global Flu Prevention Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Flu Prevention Sales by Application (2021-2032)
  7. 5.2.3 Global Flu Prevention Sales Market Share by Application (2021-2032)
  8. 5.3 Global Flu Prevention Revenue by Application
  9. 5.3.1 Global Flu Prevention Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Flu Prevention Revenue by Application (2021-2032)
  11. 5.3.3 Global Flu Prevention Revenue Market Share by Application (2021-2032)
6 Global Flu Prevention Sales by Region
  1. 6.1 Global Flu Prevention Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Flu Prevention Sales by Region (2021-2032)
  3. 6.2.1 Global Flu Prevention Sales by Region (2021-2026)
  4. 6.2.2 Global Flu Prevention Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Flu Prevention Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Flu Prevention Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Flu Prevention Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Flu Prevention Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Flu Prevention Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Flu Prevention Revenue by Region
  1. 7.1 Global Flu Prevention Revenue by Region
  2. 7.1.1 Global Flu Prevention Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Flu Prevention Revenue by Region (2021-2026)
  4. 7.1.3 Global Flu Prevention Revenue by Region (2027-2032)
  5. 7.1.4 Global Flu Prevention Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Flu Prevention Revenue (2021-2032)
  8. 7.2.2 North America Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Flu Prevention Revenue (2021-2032)
  11. 7.3.2 Europe Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Flu Prevention Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Flu Prevention Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Flu Prevention Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 AstraZeneca
  2. 8.1.1 AstraZeneca Company Information
  3. 8.1.2 AstraZeneca Business Overview
  4. 8.1.3 AstraZeneca Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AstraZeneca Flu Prevention Product Portfolio
  6. 8.1.5 AstraZeneca Recent Developments
  7. 8.2 BCHT
  8. 8.2.1 BCHT Company Information
  9. 8.2.2 BCHT Business Overview
  10. 8.2.3 BCHT Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BCHT Flu Prevention Product Portfolio
  12. 8.2.5 BCHT Recent Developments
  13. 8.3 CSL
  14. 8.3.1 CSL Company Information
  15. 8.3.2 CSL Business Overview
  16. 8.3.3 CSL Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 CSL Flu Prevention Product Portfolio
  18. 8.3.5 CSL Recent Developments
  19. 8.4 KM Biologics
  20. 8.4.1 KM Biologics Company Information
  21. 8.4.2 KM Biologics Business Overview
  22. 8.4.3 KM Biologics Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 KM Biologics Flu Prevention Product Portfolio
  24. 8.4.5 KM Biologics Recent Developments
  25. 8.5 Sinovac
  26. 8.5.1 Sinovac Company Information
  27. 8.5.2 Sinovac Business Overview
  28. 8.5.3 Sinovac Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sinovac Flu Prevention Product Portfolio
  30. 8.5.5 Sinovac Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GSK Flu Prevention Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Hualan Bio
  38. 8.7.1 Hualan Bio Company Information
  39. 8.7.2 Hualan Bio Business Overview
  40. 8.7.3 Hualan Bio Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hualan Bio Flu Prevention Product Portfolio
  42. 8.7.5 Hualan Bio Recent Developments
  43. 8.8 Viatris
  44. 8.8.1 Viatris Company Information
  45. 8.8.2 Viatris Business Overview
  46. 8.8.3 Viatris Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Viatris Flu Prevention Product Portfolio
  48. 8.8.5 Viatris Recent Developments
  49. 8.9 Jiangsu GDK
  50. 8.9.1 Jiangsu GDK Company Information
  51. 8.9.2 Jiangsu GDK Business Overview
  52. 8.9.3 Jiangsu GDK Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu GDK Flu Prevention Product Portfolio
  54. 8.9.5 Jiangsu GDK Recent Developments
  55. 8.10 Sanofi
  56. 8.10.1 Sanofi Company Information
  57. 8.10.2 Sanofi Business Overview
  58. 8.10.3 Sanofi Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sanofi Flu Prevention Product Portfolio
  60. 8.10.5 Sanofi Recent Developments
  61. 8.11 Changchun Institute of Biological
  62. 8.11.1 Changchun Institute of Biological Company Information
  63. 8.11.2 Changchun Institute of Biological Business Overview
  64. 8.11.3 Changchun Institute of Biological Flu Prevention Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Changchun Institute of Biological Flu Prevention Product Portfolio
  66. 8.11.5 Changchun Institute of Biological Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Flu Prevention Value Chain Analysis
  2. 9.1.1 Flu Prevention Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Flu Prevention Production Mode & Process
  6. 9.2 Flu Prevention Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Flu Prevention Distributors
  9. 9.2.3 Flu Prevention Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst